annual ROE:
-32.02%+18.14%(+36.16%)Summary
- As of today (September 10, 2025), CRNX annual return on equity is -32.02%, with the most recent change of +18.14% (+36.16%) on December 31, 2024.
- During the last 3 years, CRNX annual ROE has risen by +10.96% (+25.50%).
- CRNX annual ROE is now -3.26% below its all-time high of -31.01%, reached on December 31, 2018.
Performance
CRNX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-34.15%-2.08%(-6.49%)Summary
- As of today (September 10, 2025), CRNX quarterly return on equity is -34.15%, with the most recent change of -2.08% (-6.49%) on June 30, 2025.
- Over the past year, CRNX quarterly ROE has increased by +8.28% (+19.51%).
- CRNX quarterly ROE is now -202.86% below its all-time high of 33.20%, reached on December 31, 2017.
Performance
CRNX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRNX ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +36.2% | +19.5% |
3 y3 years | +25.5% | +28.7% |
5 y5 years | +11.9% | +23.9% |
CRNX ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +36.7% | -6.5% | +41.0% |
5 y | 5-year | at high | +38.0% | -6.5% | +41.0% |
alltime | all time | -3.3% | +54.2% | -202.9% | +41.0% |
CRNX ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | -34.15%(+6.5%) |
Mar 2025 | - | -32.07%(-5.4%) |
Dec 2024 | -32.02%(-36.2%) | -33.89%(-11.6%) |
Sep 2024 | - | -38.33%(-9.7%) |
Jun 2024 | - | -42.43%(-10.0%) |
Mar 2024 | - | -47.16%(-14.8%) |
Dec 2023 | -50.16%(-0.8%) | -55.36%(-2.8%) |
Sep 2023 | - | -56.98%(-1.6%) |
Jun 2023 | - | -57.89%(+8.1%) |
Mar 2023 | - | -53.53%(+10.3%) |
Dec 2022 | -50.57%(+17.7%) | -48.53%(+1.5%) |
Sep 2022 | - | -47.80%(-0.2%) |
Jun 2022 | - | -47.89%(-5.4%) |
Mar 2022 | - | -50.60%(-1.7%) |
Dec 2021 | -42.98% | -51.48%(-5.9%) |
Sep 2021 | - | -54.68%(+11.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | -48.89%(+0.7%) |
Mar 2021 | - | -48.57%(+3.3%) |
Dec 2020 | -51.61%(+41.9%) | -47.04%(+5.1%) |
Sep 2020 | - | -44.77%(-0.2%) |
Jun 2020 | - | -44.88%(-0.8%) |
Mar 2020 | - | -45.23%(+25.8%) |
Dec 2019 | -36.36%(+17.3%) | -35.94%(+21.8%) |
Sep 2019 | - | -29.51%(+8.5%) |
Jun 2019 | - | -27.19%(+10.1%) |
Mar 2019 | - | -24.69%(+6.7%) |
Dec 2018 | -31.01%(-55.6%) | -23.15%(+13.3%) |
Sep 2018 | - | -20.44%(-36.1%) |
Jun 2018 | - | -32.00%(+18.2%) |
Mar 2018 | - | -27.07%(-181.5%) |
Dec 2017 | -69.86%(+33.9%) | 33.20% |
Dec 2016 | -52.18% | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual return on equity?
- What is the all time high annual ROE for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of CRNX is -32.02%
What is the all time high annual ROE for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual return on equity is -31.01%
What is Crinetics Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, CRNX annual return on equity has changed by +18.14% (+36.16%)
What is Crinetics Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of CRNX is -34.15%
What is the all time high quarterly ROE for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly return on equity is 33.20%
What is Crinetics Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, CRNX quarterly return on equity has changed by +8.28% (+19.51%)